ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesG72.0

G72.0

Billable

Drug-induced myopathy

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 G72.0 is a billable code used to indicate a diagnosis of drug-induced myopathy.

Key Diagnostic Point:

Drug-induced myopathy is a condition characterized by muscle weakness and dysfunction resulting from the use of certain medications. This condition can arise from various drug classes, including corticosteroids, statins, and certain antiretrovirals. Patients may present with symptoms such as muscle pain, weakness, and fatigue, which can significantly impact their quality of life. The pathophysiology often involves direct muscle toxicity or an immune-mediated response triggered by the drug. Diagnosis typically requires a thorough patient history, including a review of medications, physical examination, and laboratory tests such as creatine kinase levels. Electromyography (EMG) and muscle biopsy may also be utilized to confirm the diagnosis and rule out other myopathies. Management involves discontinuation of the offending agent and supportive care, with some cases requiring corticosteroids or other immunosuppressive therapies. Understanding the relationship between drug exposure and muscle symptoms is crucial for effective diagnosis and treatment.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of drugs that can cause myopathy
  • Need for comprehensive patient medication history
  • Differentiation from other myopathies and neuromuscular disorders
  • Potential for overlapping symptoms with other conditions

Audit Risk Factors

  • Inadequate documentation of drug history
  • Failure to link symptoms to specific medications
  • Misdiagnosis due to overlapping symptoms with other myopathies
  • Lack of follow-up documentation on symptom resolution after drug discontinuation

Specialty Focus

Medical Specialties

Neurology

Documentation Requirements

Detailed history of medication use, symptom onset, and neurological examination findings.

Common Clinical Scenarios

Patients presenting with unexplained muscle weakness after starting new medications.

Billing Considerations

Consideration of other neuromuscular disorders that may mimic drug-induced myopathy.

Rheumatology

Documentation Requirements

Comprehensive review of autoimmune conditions and medications that may contribute to myopathy.

Common Clinical Scenarios

Patients with autoimmune diseases on immunosuppressive therapy presenting with muscle weakness.

Billing Considerations

Differentiating between drug-induced myopathy and myopathy related to the underlying autoimmune condition.

Coding Guidelines

Inclusion Criteria

Use G72.0 When
  • Follow the official ICD
  • CM coding guidelines, ensuring accurate documentation of the drug causing the myopathy and correlating symptoms
  • Include any relevant history of drug use and the timeline of symptom onset

Exclusion Criteria

Do NOT use G72.0 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

95860CPT Code

Electromyography, each limb

Clinical Scenario

Used to evaluate muscle function in patients suspected of having drug-induced myopathy.

Documentation Requirements

Document the reason for the EMG, including symptoms and medication history.

Specialty Considerations

Neurologists should ensure comprehensive documentation linking EMG findings to the diagnosis.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of drug-induced myopathy, improving the ability to track and analyze cases related to medication use. This specificity aids in better patient management and research into drug safety.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of drug-induced myopathy, improving the ability to track and analyze cases related to medication use. This specificity aids in better patient management and research into drug safety.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of drug-induced myopathy, improving the ability to track and analyze cases related to medication use. This specificity aids in better patient management and research into drug safety.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What are the common drugs associated with drug-induced myopathy?

Common drugs include statins, corticosteroids, and certain antiretroviral medications. It is essential to review the patient's medication history to identify potential culprits.